Micro-sized cold atmospheric plasma source for brain and breast cancer treatment
Authors:
Zhitong Chen,
Li Lin,
Qinmin Zheng,
Jonathan H. Sherman,
Jerome Canady,
Barry Trink,
Michael Keidar
Abstract:
Micro-sized cold atmospheric plasma (uCAP) has been developed to expand the applications of CAP in cancer therapy. In this paper, uCAP devices with different nozzle lengths were applied to investigate effects on both brain (glioblastoma U87) and breast (MDA-MB-231) cancer cells. Various diagnostic techniques were employed to evaluate the parameters of uCAP devices with different lengths such as po…
▽ More
Micro-sized cold atmospheric plasma (uCAP) has been developed to expand the applications of CAP in cancer therapy. In this paper, uCAP devices with different nozzle lengths were applied to investigate effects on both brain (glioblastoma U87) and breast (MDA-MB-231) cancer cells. Various diagnostic techniques were employed to evaluate the parameters of uCAP devices with different lengths such as potential distribution, electron density, and optical emission spectroscopy. The generation of short- and long-lived species (such as hydroxyl radical (.OH), superoxide (O2-), hydrogen peroxide (H2O2), nitrite (NO2-), et al) were studied. These data revealed that uCAP treatment with a 20 mm length tube has a stronger effect than that of the 60 mm tube due to the synergetic effects of reactive species and free radicals. Reactive species generated by uCAP enhanced tumor cell death in a dose-dependent fashion and was not specific with regards to tumor cell type.
△ Less
Submitted 18 April, 2018;
originally announced April 2018.
The cellular ROS-scavenging function, a key factor determining the specific vulnerability of cancer cells to cold atmospheric plasma in vitro
Authors:
Dayun Yan,
Jonathan H. Sherman,
Jerome Canady,
Barry Trink,
Michael Keidar
Abstract:
Cold atmospheric plasma (CAP) has shown its promising application in cancer treatment both in vitro and in vivo. However, the anti-cancer mechanism is still largely unknown. CAP may kill cancer cells via triggering the rise of intracellular ROS, DNA damage, mitochondrial damage, or cellular membrane damage. While, the specific vulnerability of cancer cells to CAP has been observed, the underlying…
▽ More
Cold atmospheric plasma (CAP) has shown its promising application in cancer treatment both in vitro and in vivo. However, the anti-cancer mechanism is still largely unknown. CAP may kill cancer cells via triggering the rise of intracellular ROS, DNA damage, mitochondrial damage, or cellular membrane damage. While, the specific vulnerability of cancer cells to CAP has been observed, the underlying mechanism of such cell-based specific vulnerability to CAP is completely unknown. Here, through the comparison of CAP treatment and H2O2 treatment on 10 different cancer cell lines in vitro, we observed that the H2O2 consumption speed by cancer cells was strongly correlated to the cytotoxicity of CAP treatment on cancer cells. Cancer cells that clear extracellular H2O2 more quickly are more resistant to the cytotoxicity of CAP treatment. This finding strongly indicates that the anti-oxidant system in cancer cells play a key role in the specific vulnerability of cancer cells to CAP treatment in vitro.
△ Less
Submitted 24 November, 2017;
originally announced November 2017.